1. Home
  2. SKYH vs DCTH Comparison

SKYH vs DCTH Comparison

Compare SKYH & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sky Harbour Group Corporation

SKYH

Sky Harbour Group Corporation

HOLD

Current Price

$10.24

Market Cap

327.2M

Sector

Industrials

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$12.25

Market Cap

372.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKYH
DCTH
Founded
2017
1988
Country
United States
United States
Employees
112
N/A
Industry
Military/Government/Technical
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
327.2M
372.5M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
SKYH
DCTH
Price
$10.24
$12.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$13.13
$22.00
AVG Volume (30 Days)
177.1K
379.0K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
107.53
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$78.89
$24.54
Revenue Next Year
$73.15
$33.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.22
$8.12
52 Week High
$11.17
$13.74

Technical Indicators

Market Signals
Indicator
SKYH
DCTH
Relative Strength Index (RSI) 56.35 44.31
Support Level $9.63 $9.98
Resistance Level $10.47 $12.48
Average True Range (ATR) 0.43 0.51
MACD 0.02 -0.17
Stochastic Oscillator 64.76 1.71

Price Performance

Historical Comparison
SKYH
DCTH

About SKYH Sky Harbour Group Corporation

Sky Harbour Group Corp is an aviation infrastructure company focused on building the first nationwide network of Home Base Operator (HBO) campuses designed exclusively for business aircraft. The company develops, leases, and manages general aviation hangars across the United States, targeting airfields in markets with aircraft populations and high hangar demand. Its HBS campuses include private hangars and offer a range of services tailored to aircraft owners operating from these facilities. The majority of the company's revenue is derived from the leasing of home-based aircraft hangars and through services and products ancillary to its leasing activities.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: